Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Journalist and author Henry Grabar on NYC’s Congestion Pricing and how this could help the Democratic Party. Dr. Silviu Itescu, CEO at Mesoblast, on MESO stock soaring after FDA stem cell therapy approval. And we Drive to the Close with Tony Roth CIO at Wilmington Trust

Hosts:Carol Massar and Tim Stenovec. Producer: Paul Brennan and Sebastian Escobar

Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Journalist and author Henry Grabar on NYC&rsquo;s Congestion Pricing and how this could help the Democratic Party. Dr. Silviu Itescu, CEO at Mesoblast, on MESO stock soaring after FDA stem cell therapy approval. And we Drive to the Close with Tony Roth CIO at Wilmington Trust Hosts:Carol Massar and Tim Stenovec. Producer: Paul Brennan and Sebastian Escobar

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology. You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec cover the changing world of money, power and technology.&nbsp;You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

NYC Congestion Pricing, Stem Cell Therapy

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/20b96aab-f8d4-4b3a-a977-b25d015b5b0a/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Micron Technology Inc., the largest US maker of computer memory chips, delivered a sales forecast that topped Wall Street estimates after AI-fueled shortages of the components sent prices soaring.
Revenue will be approximately $50 billion in the fiscal fourth quarter, which runs through August, the company said in a statement Wednesday. Analysts estimated $43.2 billion on average. Excluding some items, profit will be about $31 a share, compared with a projection of $25.31.

The shares climbed about 5% in late trading after the report was released. They had already more than tripled this year, outpacing all other major chip stocks.

Micron and its peers in the memory space — Samsung Electronics Co. and SK Hynix Inc. — have become major beneficiaries of the artificial intelligence boom. A spending spree by data center operators has stoked the appetite for both conventional memory and a newer variety called high-bandwidth memory, or HBM, that works with AI systems.

On this episode, Carol Massar Tim Stenovec speak with:
Ed Ludlow, Bloomberg Tech Host AND Jake Silverman, Bloomberg Intelligence Semiconductor Analyst
Katie Hubbard, President, U.S. Capital Markets for Walton Global on state of the US housing market
Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council
Len Tannenbaum, Founder, Tannenbaum Capital Group AND James Crombie, Bloomberg News Senior Editor, Credit on private credit latest

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Micron Technology Inc., the largest US maker of computer memory chips, delivered a sales forecast that topped Wall Street estimates after AI-fueled shortages of the components sent prices soaring. Revenue will be approximately $50 billion in the fiscal fourth quarter, which runs through August, the company said in a statement Wednesday. Analysts estimated $43.2 billion on average. Excluding some items, profit will be about $31 a share, compared with a projection of $25.31. The shares climbed about 5% in late trading after the report was released. They had already more than tripled this year, outpacing all other major chip stocks. Micron and its peers in the memory space &mdash; Samsung Electronics Co. and SK Hynix Inc. &mdash; have become major beneficiaries of the artificial intelligence boom. A spending spree by data center operators has stoked the appetite for both conventional memory and a newer variety called high-bandwidth memory, or HBM, that works with AI systems. On this episode, Carol Massar Tim Stenovec speak with:
<ul>
<li>Ed Ludlow, Bloomberg Tech Host AND Jake Silverman, Bloomberg Intelligence Semiconductor Analyst</li>
<li>Katie Hubbard, President, U.S. Capital Markets for Walton Global on state of the US housing market</li>
<li>Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council</li>
<li>Len Tannenbaum, Founder, Tannenbaum Capital Group AND James Crombie, Bloomberg News Senior Editor, Credit on private credit latest</li>
</ul>

Micron Sales Forecast Tops Estimates on Insatiable Memory Demand

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c2b78116-c979-4d9b-b9da-b4730159224e/transcript

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

In an industrial park a half-hour outside Prague, Peter Magic finds himself at the center of a gold rush. In the 15 years since he started his business as a teenager in his parents’ garage in Slovakia, it’s developed into a fast-growing company with almost nine figures in annual revenue and an international clientele. He isn’t training a new kind of agentic artificial intelligence that replaces your employer’s legal department or building the next online prediction market. His company, Janoshik Analytical, does purity and sterility testing for black-market anabolic steroids, an obscure niche Magic found during his own foray into weightlifting. His search for other lifters online took him to 4chan and Reddit, where many talked freely about their pharmaceutical experimentation but fretted about what might be in their drugs. Magic figured testing steroid samples couldn’t be that hard. “It took a couple of years, actually, before we got all the processes perfected, because obviously, legally, this is pretty thin ice,” he says. Among connoisseurs, his testing has become the gold standard. Outside, in his lab’s parking lot, he has the shimmering purple Ferrari to prove it.

As it turns out, Magic’s reputation for running a legitimate business evaluating illicit substances has positioned him perfectly for a new black market: the global trade in peptides. For more on the show, Carol Massar and Tim Stenovec, spoke with Amanda Mull, Bloomberg Businessweek Senior Reporter and Madison Muller, Bloomberg News US Health Care Reporter

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.
In an industrial park a half-hour outside Prague, Peter Magic finds himself at the center of a gold rush. In the 15 years since he started his business as a teenager in his parents&rsquo; garage in Slovakia, it&rsquo;s developed into a fast-growing company with almost nine figures in annual revenue and an international clientele. He isn&rsquo;t training a new kind of agentic artificial intelligence that replaces your employer&rsquo;s legal department or building the next online prediction market. His company, Janoshik Analytical, does purity and sterility testing for black-market anabolic steroids, an obscure niche Magic found during his own foray into weightlifting. His search for other lifters online took him to 4chan and Reddit, where many talked freely about their pharmaceutical experimentation but fretted about what might be in their drugs. Magic figured testing steroid samples couldn&rsquo;t be that hard. &ldquo;It took a couple of years, actually, before we got all the processes perfected, because obviously, legally, this is pretty thin ice,&rdquo; he says. Among connoisseurs, his testing has become the gold standard. Outside, in his lab&rsquo;s parking lot, he has the shimmering purple Ferrari to prove it.
As it turns out, Magic&rsquo;s reputation for running a legitimate business evaluating illicit substances has positioned him perfectly for a new black market: the global trade in peptides. For more on the show, Carol Massar and Tim Stenovec, spoke with Amanda Mull, Bloomberg Businessweek Senior Reporter and Madison Muller, Bloomberg News US Health Care Reporter

The Billion-Dollar Peptides Gold Rush

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/aea9e576-7775-412d-a0b6-b472016fca82/transcript

Tuesday’s stock-market slide was what one Wall Street strategist called a “chip-wreck.”The semiconductor companies that have led this year’s stock-market advance with triple-digit percentage gains were suddenly hit with a wave of doubts about the sustainability of the AI-driven rally. 

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

On this episode, Tim Stenovec and Carol Massar speak with:
Amanda Lyons, Head of Research, Energy Group Capital
Sean Gadd, CEO of Latham Group
Katherine Kostereva, CEO of Creatio
Gracelin Baskaran, Director, Critical Minerals Security Program at the Center for Strategic and International Studies

Tuesday&rsquo;s stock-market slide was what one Wall Street strategist called a &ldquo;chip-wreck.&rdquo;The semiconductor companies that have led this year&rsquo;s stock-market advance with triple-digit percentage gains were suddenly hit with a wave of doubts about the sustainability of the AI-driven rally.&nbsp;
The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.
On this episode, Tim Stenovec and Carol Massar speak with:
<ul>
<li>Amanda Lyons, Head of Research, Energy Group Capital</li>
<li>Sean Gadd, CEO of Latham Group</li>
<li>Katherine Kostereva, CEO of Creatio</li>
<li>Gracelin Baskaran, Director, Critical Minerals Security Program at the Center for Strategic and International Studies</li>
</ul>

US Chip Stocks Plunge as AI Selloff Ripples Across From Asia

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cca9875e-d53c-44be-a5b0-b4720171040d/transcript

NYC Congestion Pricing, Stem Cell Therapy

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips